BioBridgeXAll companies

Arvinas, Inc.

Pharmaceutical company · New Haven, Connecticut, United States · Nasdaq: ARVN

Arvinas, Inc. is a pharmaceutical company headquartered in New Haven, Connecticut, United States. Its earliest recorded incorporation is in 2013. Its shares trade on Nasdaq under the ticker ARVN. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $1.1 million in total, most recently in 2016. It has reported private securities offerings to the US SEC, most recently $32 million sold in a notice filed in 2019.

www.arvinas.comProfile compiled from public records. Is this your company? Request a correction or update

Arvinas at a glance

Typepharmaceutical company
HeadquartersNew Haven, Connecticut, United States
Earliest incorporation on record2013
Stock listingNasdaq: ARVN
SEC industryPharmaceutical Preparations
Employees (per SBIR records)20

What does Arvinas do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $1.1 million in total (2016). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $32.5 million sold (2019).

Frequently asked questions about Arvinas

Where is Arvinas headquartered?

Arvinas, Inc. is headquartered in New Haven, Connecticut, United States.

What does Arvinas do?

Arvinas, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Arvinas a public company?

Yes. Arvinas, Inc. trades on Nasdaq under the ticker ARVN.

When was Arvinas founded?

The earliest incorporation on record for Arvinas, Inc. is in 2013, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.